A dual DNA/RNA-binding factor regulates co-transcriptional splicing through target RNA interaction and modulates splicing factor dynamics

The study reveals that the conserved transcription factor CLAMP regulates context-specific co-transcriptional splicing by directly binding both GA-rich DNA and target RNAs via its prion-like domain, thereby modulating the dynamics of hnRNPA2/B1 family proteins to ensure precise sex-specific transcript diversity.

The Gist

Imagine your body's genetic code (DNA) as a massive, ancient library containing the instructions for building and running a human being. But here's the catch: the library doesn't just hand you the books; it has to edit them first. It cuts out unnecessary chapters and stitches the important ones together to create the final story. This editing process is called splicing.

The problem is, this editing happens while the book is still being written. If the editor makes a mistake, the story becomes gibberish, which can lead to disease. So, how does the cell know exactly where to cut and paste in the right context (like making a male vs. a female cell)?

This paper introduces a "super-editor" named CLAMP and explains how it acts as a master coordinator to ensure the editing happens correctly, specifically to create differences between males and females.

Here is the story of how CLAMP works, broken down into simple analogies:

1. The Double-Agent Editor (CLAMP)

Most editors in the library only know how to read the original manuscript (DNA). But CLAMP is special. It's a dual-agent:

• It reads the DNA: It knows exactly where in the library the book is located.
• It reads the RNA: It also grabs the "draft" copy of the book (the RNA) that is being written.

By holding onto both the location (DNA) and the draft (RNA) at the same time, CLAMP acts like a conductor standing on the podium, ensuring the orchestra (the splicing machinery) plays the right notes at the right time.

2. The "Prion-Like" Magic Wand (The PrLD Domain)

The paper focuses on a specific part of the CLAMP protein called the PrLD (Prion-Like Domain). Think of this as a magic wand or a molecular Velcro strip.

• This part of CLAMP is floppy and unstructured (like a piece of yarn), which allows it to grab onto other things easily.
• The researchers found that if you cut off this "magic wand," CLAMP loses its ability to grab the RNA drafts. Without this grip, the editing process falls apart.

3. The "Traffic Controller" for Splicing (Hrp38)

CLAMP doesn't do all the cutting and pasting alone. It partners with a worker named Hrp38 (which is similar to a human protein called hnRNPA2/B1).

• Imagine Hrp38 as a construction crew that forms a temporary, bubbling bubble of activity (a "condensate") around the book to do the editing.
• In a healthy cell, these bubbles are small, bouncy, and move around quickly. This allows them to edit efficiently and then move on to the next book.

4. The Gender Difference: Why Males and Females are Different

The paper discovered that CLAMP uses its "magic wand" to treat males and females differently:

• In Males: CLAMP keeps the Hrp38 construction crews small, bouncy, and fast. This ensures the editing happens quickly and correctly for male-specific traits.
• In Females: The crews are a bit more sluggish and larger.
• The Breakdown: When the researchers removed CLAMP's "magic wand" (the PrLD), the Hrp38 crews in males stopped bouncing. They turned into giant, sticky blobs that couldn't move. It's like a construction crew getting stuck in a giant puddle of tar—they can't move to the next job, and the editing stops working.

5. The "Ghost" Editing (Cryptic Splicing)

When CLAMP is missing or broken, the library gets chaotic. The editors start cutting and pasting in the wrong places, creating "ghost" stories that shouldn't exist. In biology, these are called cryptic splicing events, and they are often the cause of genetic diseases. CLAMP acts as a security guard, preventing these mistakes by holding the draft steady and guiding the crew.

The Big Picture Takeaway

This paper solves a mystery: How does a protein that sits on DNA know which RNA to edit?

The answer is that CLAMP physically bridges the gap. It grabs the DNA location, grabs the RNA draft, and uses its "magic wand" to keep the editing crew (Hrp38) moving at the right speed.

• Without CLAMP: The editing crew gets stuck, the books are ruined, and the cell gets sick.
• With CLAMP: The editing is precise, the books are perfect, and the cell knows exactly how to be male or female.

In short, CLAMP is the master architect that ensures the blueprint (DNA) and the construction crew (splicing factors) are perfectly synchronized to build a healthy organism.

Technical Summary

1. Problem Statement

While transcription factors (TFs) and RNA-binding proteins (RBPs) are known to co-transcriptionally regulate alternative splicing, the mechanisms by which specific splicing events are targeted to the correct genomic locations in a cell-type-specific manner remain poorly understood. Specifically, it is unclear how TFs coordinate with RBPs to:

• Prevent deleterious cryptic splicing events.
• Generate context-specific transcript diversity (e.g., sex-specific splicing).
• Link DNA binding sites directly to RNA targets at intron-exon boundaries.

The authors hypothesized that a subset of TFs possessing both DNA and RNA binding capabilities are critical for targeting co-transcriptional splicing to specific genomic loci. They selected the Drosophila GA-binding transcription factor CLAMP as a model system to test this, given its role in sex-specific splicing, its enrichment at intronic regions of spliced genes, and its interaction with spliceosomal components.

2. Methodology

The study employed a multidisciplinary approach combining in vivo genetics, genomics, structural biology, and biophysics:

• Genomic Approaches:
  • Fractionation iCLIP (CrossLinking and ImmunoPrecipitation): Performed on male (S2) and female (Kc) Drosophila cell lines to map CLAMP-RNA interactions in nucleoplasmic vs. chromatin fractions.
  • CUT&RUN: Used to map CLAMP-DNA binding sites in the same cell lines.
  • RNA-seq: Conducted on third-instar larvae (L3) of wild-type and clamp mutants to identify sex-specific splicing changes.
  • Bioinformatics: Developed a tool ("Bindcompare") to correlate CLAMP RNA peaks with DNA peaks; used the time2splice pipeline for splicing analysis.
• Genetic Manipulation:
  • Generated CRISPR/Cas9-mediated clamp mutant fly lines with deletions in the Prion-like domain (PrLD): a complete deletion (clampΔ154-290) and a partial deletion retaining 6 glutamines (clampΔ160-290+6Q).
• Biochemical & Structural Analysis:
  • Protein Purification: Expressed and purified full-length CLAMP, PrLD-deleted CLAMP, and the PrLD fragment (aa 1-300).
  • NMR Spectroscopy: Used to characterize the disordered nature of the PrLD and its direct interaction with RNA.
  • RNA-Protein EMSA (Electrophoretic Mobility Shift Assay): Tested binding affinity of CLAMP variants to specific RNA probes (e.g., roX2, hrp38 exons).
• Biophysical & Imaging Analysis:
  • Phase Separation Assays: In vitro co-phase separation of CLAMP and its partner Hrp38 (an hnRNPA2/B1 orthologue).
  • Live Imaging & FRAP: Used third-instar larval tissues (salivary glands and Malpighian tubules) expressing Hrp38-GFP to measure nuclear speckle size, mobility, and recovery rates in wild-type vs. clamp mutants.
  • Co-localization Analysis: Quantified Pearson Correlation Coefficients between CLAMP and Hrp38 in fixed tissues.

3. Key Contributions

• Dual Binding Mechanism: Demonstrated that CLAMP functions as a "dual" binder, physically linking specific DNA motifs to target RNAs on chromatin to regulate co-transcriptional splicing.
• Role of the PrLD: Identified the Prion-like domain (PrLD) of CLAMP as essential not just for protein phase separation, but specifically for high-affinity RNA binding and the regulation of splicing factor dynamics.
• Mechanism of Splicing Regulation: Revealed a novel mechanism where a TF regulates splicing by modulating the biophysical properties (size and dynamics) of RBP condensates (specifically Hrp38), rather than just recruiting splicing machinery.
• Sex-Specificity: Elucidated how differential interactions between CLAMP, RNA, and RBPs drive sex-specific splicing outcomes.

4. Key Results

A. CLAMP Binds RNA on Chromatin

• iCLIP data revealed that ~92% of CLAMP-RNA interactions in males and ~58% in females occur on chromatin.
• CLAMP interacts with distinct spliceosomal RNAs in males (U2, U5, U6 snRNAs) versus females (U1/U2-associated transcripts).
• Spatial Correlation: ~71% (males) and ~90% (females) of CLAMP-RNA peaks overlap or are proximal (<1 kb) to CLAMP-DNA binding sites, with nearly 50% within 250 bp of the DNA peak center. This confirms CLAMP links DNA and RNA at specific loci.

B. The PrLD is Essential for RNA Binding

• NMR & EMSA: The PrLD (aa 154-290) is an intrinsically disordered region (IDR) that directly binds RNA.
• Deletion of the PrLD (clampΔPrLD) significantly reduced CLAMP's ability to bind RNA in vitro (e.g., to roX2 and hrp38 RNAs).
• The presence of specific RNA secondary structures (e.g., stem-loops in roX2) enhances CLAMP binding, but the PrLD is the primary driver of the interaction.

C. PrLD Regulates Sex-Specific Splicing

• Genetic Phenotype: Complete PrLD deletion is embryonic lethal. Partial deletion mutants (clampΔPrLD+6Q) survive but exhibit severe splicing defects.
• Splicing Analysis: In clamp mutants, >70% of CLAMP-dependent splicing events are sex-specific. Notably, the loss of PrLD leads to the emergence of cryptic splicing events (aberrant splicing not seen in wild-type).
• Target Gene (hrp38): CLAMP binds the hrp38 transcript (an orthologue of human hnRNPA2B1) at exon 1 on chromatin. In clamp mutants, hrp38 fails to splice correctly, retaining exon 2. This confirms CLAMP directly regulates the splicing of a key splicing factor.

D. Modulation of Hrp38 Condensate Dynamics

• Phase Separation: CLAMP and Hrp38 co-phase-separate in vitro. The CLAMP PrLD is required for this interaction.
• In Vivo Dynamics:
  • In wild-type males, Hrp38 forms small, highly dynamic nuclear speckles.
  • In clamp PrLD mutants, Hrp38 forms larger, immobile aggregates in both sexes, but the effect is more pronounced in males.
  • FRAP analysis showed increased immobile fractions of Hrp38 in mutants, indicating a loss of condensate fluidity.
• Sex-Specific Interaction: CLAMP and Hrp38 co-localize less in wild-type males (likely due to CLAMP being sequestered by the MSL complex for dosage compensation) compared to females. In clamp mutants, this co-localization increases, suggesting the PrLD normally prevents aberrant Hrp38 aggregation in males.

5. Significance

This study provides a comprehensive model for how transcription factors can act as "bridges" between the genome and the transcriptome to ensure splicing fidelity:

1. Targeting Mechanism: TFs like CLAMP can physically tether nascent RNA to specific DNA loci via dual binding, ensuring splicing factors are recruited to the correct genomic context.
2. Biophysical Regulation: The PrLD domain of a TF acts as a rheostat for the biophysical state of splicing condensates. By preventing the formation of large, non-functional aggregates of RBPs (like Hrp38), the TF ensures high-fidelity alternative splicing.
3. Disease Relevance: The findings suggest that mutations in TF PrLDs or the disruption of TF-RNA interactions could lead to cryptic splicing and the formation of pathological protein aggregates, mechanisms often implicated in neurodegenerative diseases and cancer.
4. Sex-Specificity: The work highlights how the interplay between TFs, RNA targets, and RBP partners can be tuned by cellular context (sex) to generate diverse transcriptomes.

In summary, the paper establishes that CLAMP regulates co-transcriptional splicing by directly binding RNA via its PrLD, linking RNA to DNA, and modulating the phase separation dynamics of its partner protein Hrp38 to prevent aberrant splicing and aggregation.